| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.44欧元,归母净利润3.04亿欧元,同比去年增长245.36%
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益0.26欧元,归母净利润1.77亿欧元,同比去年增长387.57%
|
| 2025-04-11 |
详情>>
业绩披露：
2024年年报每股收益0.23欧元,归母净利润1.57亿欧元,同比去年增长164.55%
|
| 2025-04-11 |
详情>>
业绩披露：
2022年年报每股收益0.27欧元,归母净利润1.85亿欧元,同比去年增长-1.96%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.13欧元,归母净利润8795.20万欧元,同比去年增长718.25%
|
| 2024-07-30 |
详情>>
业绩披露：
2024年中报每股收益0.05欧元,归母净利润3625.90万欧元,同比去年增长-26.66%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益0.16欧元,归母净利润2141.90万欧元,同比去年增长119.78%
|
| 2024-04-19 |
详情>>
业绩披露：
2021年年报每股收益0.28欧元,归母净利润1.89亿欧元,同比去年增长-69.49%
|
| 2024-04-19 |
详情>>
业绩披露：
2023年年报每股收益0.09欧元,归母净利润5931.50万欧元,同比去年增长-67.94%
|
| 2023-07-27 |
详情>>
业绩披露：
2023年中报每股收益0.14欧元,归母净利润4943.90万欧元,同比去年增长-65.58%
|
| 2023-05-12 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of results relating to the fiscal year ended December 31, 2022.
2.Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2022.
3.Review and approval, as the case may be, of the consolidated non-financial information statement included in the consolidated management report relating to the fiscal year ended December 31, 2022.
4.Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2022.
5.Re-election of auditor of the consolidated annual accounts for fiscal year 2023.
6.Appointment of auditor of the consolidated annual accounts for fiscal years 2024, 2025 and 2026, inclusive.
7.Resignation, dismissal, re-election and/or appointment, as the case may be,of directors. Modification, if applicable, of the number of members of the Board of Directors:7.1.Re-election of Mr. Raimon Grifols Roura as a member of the Board of Directors.
7.2.Re-election of Mr. Tomas Dagá Gelabert as a member of the Board of Directors.
7.3.Re-election of Ms. Carina Szpilka Lázaro as a member of the Board of Directors.
7.4.Re-election of Mr. íigo Sanchez-Asiain Mardones as a member of the Board of Directors.
7.5.Re-election of Ms. Enriqueta Felip Font as a member of the Board of Directors.
7.6.Maintenance of vacancy and number of members of the Board of Directors.
8.Amendment of article 20.bis of the Company's Articles of Association, regarding the remuneration of the Board of Directors.
9.Information on the amendments of the Internal Regulations of the Company's Board of Directors, pursuant to article 528 of the Capital Companies Act.
10.Consultative vote on the Annual Remuneration Report.
11.Approval of the directors' remuneration policy of the Company.
12.Approval of a Stock Option Plan.
13.Approval of the award of stock options over Company shares to the Executive Chairman and Chief Executive Officer.
14.Renewal of the delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to apply for the listing of the Company's ordinary Class A shares on the NASDAQ. Revocation of the previous delegation of authorities passed by the Ordinary General Shareholders' Meeting of 9 October 2020.
15.Authorization to the Board of Directors to call, if necessary, an Extraordinary General Shareholders' Meeting of the Company with at least 15 days in advance, in accordance with Article 515 of the Capital Companies Act.
16.Granting of authorities to formalize and execute the resolutions passed by the General Shareholders' Meeting.
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益-0.32欧元,归母净利润-1.08亿欧元,同比去年增长-303.09%
|
| 2023-04-18 |
详情>>
股本变动：
变动后总股本68755.49万股
变动原因 ▼▲
- 原因：
- From December 31, 2021 to December 31, 2022
Net change in treasury stock
|
| 2022-05-06 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of results relating to the fiscal year ended December 31, 2021.
2.Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2021.
3.Review and approval, as the case may be, of the consolidated non-financial information statement included in the consolidated management report relating to the fiscal year ended December 31, 2021.
4.Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2021.
5.Re-election of auditor of the consolidated annual accounts.
6.Resignation, dismissal, re-election and/or appointment, as the case may be, of directors. Modification, if applicable, of the number of members of the Board of Directors:
6.1Information on the non-re-election of Ms. Belen Villalonga Morenes as member of the Board of Directors due to expiration of her term.
6.2Information on the non-re-election of Ms. Marla E. Salmon as member of the Board of Directors due to expiration of her term.
6.3Appointment of Ms. Montserrat Munoz Abellana as member of the Board of Directors.
6.4Appointment of Ms. Susana Gonzalez Rodriguez as member of the Board of Directors.
7.Amendment of the Company's Articles of Association:
7.1Amendment of articles 16 and 17.bis related to the right to attend, proxy granting and representation at the General Shareholders’ Meeting and the casting of votes through distance voting systems in order to adequate their content to the latest amendments of the Capital Companies Act as well as introducing substantive and technical improvements in their wording.
7.2Amendment of article 20.bis related to the remuneration of the Board of Directors in order to adequate its content to the latest amendments of the Capital Companies Act as well as introducing substantive and technical improvements in its wording.
7.3Amendment of article 24.ter related to the Audit Committee to adequate its content to the latest amendments of the Capital Companies Act as well as introducing substantive and technical improvements in its wording.
7.4Amendment of article 25 related to the annual accounts to adequate its content to the Capital Companies Act.
8.Amendment of the Regulations of the General Shareholders' Meeting:
8.1Amendment of article 9 related to the information right available for shareholders prior to the holding of the General Meeting in order to adequate its content to the latest amendments of the Capital Companies Act as well as introducing substantive and technical improvements in its wording.
8.2Amendment of articles 11.bis, 20 and 22 related to the attendance by telematic means, distance voting and the minutes of the General Shareholders' Meeting to adequate their content to the latest amendments of the Capital Companies Act as well as introducing substantive and technical improvements in their wording.
9.Information on the amendments of the Internal Regulations of the Company's Board of Directors, pursuant to article 528 of the Capital Companies Act.
10.Consultative vote on the Annual Remuneration Report.
11.Approval of the directors' remuneration policy of the Company.
12.Authorization to the Board of Directors to call, if necessary, an Extraordinary General Shareholders' Meeting of the Company with at least 15 days in advance, in accordance with Article 515 of the Capital Companies Act.
13.Granting of authorities to formalize and execute the resolutions passed by the General Shareholders' Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-21召开股东大会
会议内容 ▼▲
- 1.Review and approva1,as the case may be, of the individual annual accounts
and managemment report, as well as the proposal for allocation of results relating to the fiscal year ended December 31,2020, and approval of a preferred
dividend corresponding to Class B shares.
2.Review and approval, as the case may be, of the consolidated annual accounts
and management report relating to the fiscal year ended December 31,220.
3.Review and approval, as the case may be,of the consolidated non-financial
information statement included in the consolidated management report relating
to the fiscal year ended December 31,2020.
4.Approval, as the case may be, of the distribution of an ordinary dividend charged to voluntary reserves.
5.Review and approval, as the case may be, of the performance of the board of directors throughout the fiscal year ended december 13,2020.
6.Appointment of auditor of the individual annual accounts
7.Re-election of auditor of the consolidated annual accounts
8.Reignation,dismissal, re-election and/or appointment, as the case may be,of
directors. Modification,if applicable,of the number of members of the Board
of Directors:
8.1Resignation of Mr. Ramon Riera Roca as a member of the Board of Directors
8.2.Re-election of Mr. Victor Grifols Roura as a member of the Board of Directors
8.3.Reduction in the number of members of the Board of Directors
9.Information on the amendments of the internal Regualtions of the Company's Board of Dorectors, pursuant to article 528 of the Capital Companies Act.
10.Consultative vote on the Annual Remuneration Report
11.Delegation to the board of directors, with full power of substitution on any of its members, of the authority to increase the company's share capital pursuant to the provisions of article of the capital companies act, within the legal term of fice years as of the date of this general shareholder's meeting up to a maximum amount equivalent to 50% of the company;s share capital as of the date of this authorization, being enabled to carry out the increase at once or in several times. Pursuant to the provisions of article 506 of the capital companies act, delegation to the board of directors, with full power of substitution on any of its members, of the authority to exclude the pre-emptive subscription rights in the relevant capital increase, up to the limit of 20% of the share capital. To revoke the resolution of delegation to the Board of directors of the authority to increase the company's share capital passed on 27 May 2016.
12.Granting of authorities to formalize and execute the resolutions passed by the General Shareholders' Meeting.
|
| 2020-09-04 |
股东大会：
将于2020-10-08召开股东大会
会议内容 ▼▲
- 1.Review andl approva1,as the case may be, of the individual annual accounts
and managemment report, as well as the proposal for allocation ofresults relating
to the fiscal year ended December 31,2019, and approval of a preferred
dividend corresponding to Class B shares.
2.Review and approval, as the case mmay be,of the consolidated annual accounts
and management report relating to the fiscal year ended December 31,2019.
3.Review and approval, as the case may be,of the consolidated non-financial
information statement inecluded in the consolidated management report relating
to the fiscal year ended December 31,2019.
4.Review and approval, as the case may be,of the performanece of the Board of
Directors throughout the fiscal year ended December 31,2019.
5.Re-election of auditors of the individual annual accounts.
6.Re-election of auditors ofthe consolidated annual accounts.
7.Reignation,dismissal, re-election andor appointment, as the case may be,of
directors.Modification,if applicable,of the number of members of the Board
of Directors:
7.1.Information on the non-re-election of Mr.Luis Isasi FernandeZ de
Bobadilla as member of the Boarrd of Directors due to expiration of
his term.
7.2.Appointment of NMr. James Costos as member of the Board of
Directors.
7.3.Re-election of Nr.VictorGrifols Deu as a member of the Boardl of
Directors.
7.4.Re-election of Nr．Thomas GlanZmann as a member of theBoard of
Directors.
7.5.Re-election of lMr.Steven F．NMayer as a member of theBoard of
Directors.
8.Amendment of article 16 of the Articles of Association，relating to the right to attend,proxy granting and representation at theGeneral Shareholders' Meeting
9.Amendment of the Regulations of theGeneral Shareholders' Meeting with the
inclusion of a new atticle 11.bis,relating to the attendance to theGenera
Shareholders' Meeting by telematic means.
10.Consultative vote on the Annual Remuneration Report.
11.Approvel of the director remuneration policy of the company.
12.Authorization for the derivative acquisition of treasury stock，revoking and leaving without effect the authorization agreed by the Ordinary General Shareholder's Meeting of May 29,2015.
13.Renewal of the delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to apply for the listing of the Companv's ordinary Class A share n the NASDAQ. Revocation of the previous delegation of authorities passed by the Ordinary General Shareholder's Meeting of May 26,2017.
14.Granting of authorities to formalize and execute the resolutions passed by the General Shareholder's Meeting.
|
| 2020-03-17 |
复牌提示：
2020-03-16 09:52:16 停牌，复牌日期 2020-03-16 09:57:16
|
| 2019-10-31 |
除权日：
美东时间 2019-12-02 每股派息0.22美元
|
| 2019-05-29 |
除权日：
美东时间 2019-06-07 每股派息0.18美元
|
| 2019-04-16 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- 1.Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of results relating to the fiscal year ended December 31, 2018, and approval of a preferred dividend corresponding to Class B shares.
2.Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2018.
3.Review and approval, as the case may be, of the consolidated non-financial information statement included in the consolidated management report relating to the fiscal year ended December 31, 2018.
4.Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2018.
5.Re-election of auditors of the individual annual accounts.
6.Re-election of auditors of the consolidated annual accounts.
7.Resignation, dismissal, re-election and/or appointment, as the case may be, of Directors. Modification, if applicable, of the number of members of the Board of Directors:
7.1.resignation of Ms.Anna Veiga Lluch as a member of the Board of Directors.
7.2.Appointment of Ms. Enriqueta Felip Font as a member of the Board of Directors.
7.3.Re-election of Mr. Ramon Grifols Roura as a member of the Board of Directors.
7.4.Re-election of Mr. Tomas Daga Gelabert as a member of the Board of Directors.
7.5.Re-election of Ms. Carina Szpilka Lazaro as a member of the Board of Directors.
7.6.Re-election of Mr. Inigo Sanchez-Asiain as a member of the Board of Directors.
8.Amendment of article 17.bis of the Articles of Association, relating to distance voting systems of the General Shareholders' Meeting.
9.Amendment of article 20 of the Regulations of the General Shareholders' Meeting, relating to distance voting systems of the General Shareholders' Meeting.
10.Information on the amendment of the Internet Regulations of the Company's Board of Directors, pursuant to article 528 of the Capital Companies Act.
11.Consultative vote on the Annual Remuneration Report.
12.Informative presentation on AMBAR(Alzheimer Management by Albumin Replacement) clinical trial.
|
| 2018-11-07 |
除权日：
美东时间 2018-11-30 每股派息0.23美元
|
| 2018-05-25 |
除权日：
美东时间 2018-06-01 每股派息0.25美元
|
| 2018-04-20 |
股东大会：
将于2018-05-25召开股东大会
会议内容 ▼▲
- 1.Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of results relating to the fiscal year ended December 31, 2017, and approval of a preferred dividend corresponding to Class B shares.
2.Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2017.
3.Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2017.
4.Re-election of auditors of the individual annual accounts.
5.Re-election of auditors of the consolidated annual accounts.
6.Resignation, dismissal, re-election and/or appointment, as the case may be, of Directors. Modification, if applicable, of the number of members of the Board of Directors:
6.1.Re-election of Ms. Belen Villalonga Morenes as a member of the Board of Directors.
6.2.Re-election of Ms. Marla E. Salmon as a member of the Board of Directors.
7.Consultative vote on the Annual Remuneration Report.
8.Granting of authorities to formalize and execute the resolutions passed by the General Meeting.
|
| 2017-11-17 |
除权日：
美东时间 2017-12-01 每股派息0.21美元
|
| 2017-05-26 |
除权日：
美东时间 2017-05-30 每股派息0.16美元
|
| 2017-04-21 |
股东大会：
将于2017-05-25召开股东大会
会议内容 ▼▲
- 1. Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of' results relating to the fiscal year ended December 31, 2016, and approval of a preferred dividend corresponding to Class B shares.
2. Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2016.
3. Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2016.
4.Appointment and/or re-election of auditors of the individual annual accounts.
5. Re-election of auditors of the consolidated annual accounts.
6. Resignation, dismissal, re-election and/or appointment, as the case may be, of Directors. Modification, if applicable, of the number of members of the Board of Directors:
6.1.-Appointment of Mr. Victor Grifols Roura as a member of the Board of Directors.
6.2.-Re-election of Mr. Ramon Riera Roca as a member of the Board of Directors.
7. Consultative vote on the Annual Remuneration Report.
8. Approval of the Board Members’remuneration.
9.Amendment of article 7 of the Regulations of the General Shareholders'Meeting concerning the competences of the General Shareholders'Meeting, in order to adapt its content to the latest amendments of the Companies Act on matters of issuance of bonds and other securities.
10.Amendment of article 24.ter of the Articles of Association concerning the Audit Committee, in order to adequate its content to the latest amendments of the Companies Act introduced by the Audit Act currently in force.
11.Information on the amendments of the Internal Regulations of the Company's Board of Directors, pursuant to article 528 of the Companies Act.
12.Renewal of the delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to apply for the listing of the Company's ordinary Class A shares on the NASDAQ. Revocation of the previous delegation of authorities passed by the Ordinary General Shareholders' Meeting of 30 May 2014.
13.Granting of authorities to formalize and execute the resolutions passed by the General Meeting.
|
| 2016-11-22 |
除权日：
美东时间 2016-12-05 每股派息0.19美元
|
| 2016-05-31 |
除权日：
美东时间 2016-06-02 每股派息0.16美元
|
| 2016-04-22 |
股东大会：
将于2016-05-26召开股东大会
会议内容 ▼▲
- 1. Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation of' results relating to the fiscal year ended December 31, 2015, and approval of a preferred dividend corresponding to Class B shares.
2. Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year ended December 31, 2015.
3. Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2015.
4. Re-election of auditors of the individual annual accounts.
5. Re-election of auditors of the consolidated annual accounts.
6. Resignation, dismissal, re-election and/or appointment, as the case may be, of Directors. Modification, if applicable, of the number of members of the Board of Directors:
6.1.-Appointment of Mr. Victor Grifols Deu as a member of the Board of Directors.
6.2.-Re-election of Mr. Luis Isasi Fernandez de Bobadilla as a member of the Board of Directors.
6.3.-Re-election of Mr. Steven F. Mayer as a member of the Board of Directors.
6.4.-Re-election of Mr. Thomas Glanzmann as a member of the Board of Directors.
6.5.-Increase in the number of members of the Board of Directors.
7. Consultative vote on the Annual Remuneration Report.
8. Delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to increase the Company's share capital pursuant to the provisions of article 297.l.b) of the Companies Act (Ley de Sociedades de Capital), within the legal term of five years as of the date of this General Shareholders' Meeting up to a maximum amount equivalent to 50% of the Company's share capital as of the date of this authorization, being enabled to carry out the increase at once or in several times. Pursuant to the provisions of article 506 of the Companies Act (Ley de Sociedades de Capital), delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to exclude the pre-emptive subscription rights in the relevant capital increases, up to the limit of 20% of the share capital. To revoke the resolution of delegation to the Board of directors of the authority to increase the Company's share capital passed on 4 December 2012.
9. Granting of authorities to formalize and execute the resolutions passed by the General Meeting.
|
| 2015-12-18 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2015-12-01 |
除权日：
美东时间 2015-12-10 每股派息0.38美元
|
| 2015-05-01 |
除权日：
美东时间 2015-06-08 每股派息0.01美元
|
| 2015-05-01 |
除权日：
美东时间 2015-06-08 每股派息0.33美元
|
| 2015-04-24 |
股东大会：
将于2015-05-29召开股东大会
会议内容 ▼▲
- 1. Review and approval, as the case may be, of the individual annual accounts and management report, as well as of the proposal for allocation of results relating to fiscal year ended December 31, 2014, and approval of a preferred dividend corresponding to Class B shares.
2. Review and approval, as the case may be, of the consolidated annual accounts and management report relating to fiscal year ended December 31, 2014.
3.Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2014.
4. Re-election of auditors of the individual annual accounts.
5. Re-election of auditors of the consolidated annual accounts.
6. Amendment of the Articles of Association:
6.1. Amendment of articles 13, 14, 15 and 17 of the Articles of Association, related to the functioning of the General Shareholders' Meeting, in order to adequate their content to the latest amendments of the Companies Act on matters of corporate governance, as well as introducing substantive and technical improvements in their wording.
6.2.Amendment of articles 20 and 24.ter of the Articles of Association and inclusion of article 24.quater, all of them concerning the composition of the Board of Directors and the Board's delegated committees, in order to adequate their content to the latest amendments of the Companies Act on matters of corporate governance.
6.3.Inclusion of articles 20.bis and 21.ter in the Articles of Association, both concerning the remuneration of the Board of Directors, in order to adequate their content to the latest amendments of the Companies Act on matters of corporate governance.
7. Amendment of the Regulations of the General Shareholders' Meeting:
7.1. Amendment of article 7 of the Regulations of the General Shareholders' Meeting, concerning the competences of the General Shareholders' Meeting, in order to adapt its content to the latest amendments of the Companies Act on matters of corporate governance.
7.2.Amendment of articles 8, 9, 16 and 19 of the Regulations of the General Shareholders' Meeting and inclusion of a new article 20.bis, all of them concerning the functioning of the General Shareholders' Meeting, in order to adequate their content to the latest amendments of the Companies Act on matters of corporate governance.
7.3. Amendment of article 11 of the Regulations of the General Shareholders' Meeting, concerning the shareholders' system of representation in the General Shareholders' Meeting, with the aim of completing and developing said representation system.
8.Resignation, dismissal, re-election and/or appointment, as the case may be, of Directors. Modification, if applicable, of the number of members of the Board of Directors.
8.1.Resignation of Mr. Edgar Dalzell Jannotta as a member of the Board of Directors.
8.2. Resignation of Mr. William Brett Ingersoll as a member of the Board of Directors.
8.3. Resignation of Thorthol Holdings B.V. as a member of the Board of Directors.
8.4. Resignation of Mr. Juan Ignacio Twose Roura as a member of the Board of Directors.
8.5. Appointment of Ms. Carina Szpilka Lazaro as a member of the Board of Directors.
8.6. Appointment of Mr. Inigo Sánchez-Asiain Mardones as a member of the Board of Directors.
8.7. Appointment of Mr. Raimon Grifols Roura as a member of the Board of Directors.
8.8. Re-election of Ms. Anna Veiga Lluch as a member of the Board of Directors.
8.9. Re-election of Mr. Tomas Daga Gelabert as a member of the Board of Directors.
8.10.Reduction of the number of members of the Board of Directors.
9. Information on the amendments of the Regulations of the Company's Board of Directors, pursuant to article 528 of the Companies Act.
10. Approval of the Board Members' remuneration.
11. Consultative vote on the Annual Remunerations Report.
12. Renewal of the resolution of share split of the Company's Class A and Class B shares, in the proportion of 2 new shares (whether of Class A or of Class B) for each 1 of the former shares (whether of Class A or of Class B), as may be applicable, by means of a decrease in their nominal value and the subsequent increase in the number of the Company's Class A and Class B shares, which will be multiplied by two, without any change to the total nominal value of the share capital, with the consequent renewal of the delegation of authorities to the Board of Directors for a term of 1 year. Amendment of Article 6 of the Company's Articles of Association (Share Capital). Application before the relevant domestic and foreign authorities for the listing of the new shares on the Stock Exchanges of Madrid, Barcelona, Bilbao and Valencia, as well as on the Spanish Automated Quotation System (Sistema de Interconexion Bursatil) (Continuous Market) and on the NASDAQ.
13.Authorization for the derivative acquisition of treasury stock, revoking and leaving without effect the authorization agreed by the Extraordinary General Shareholders’ Meeting of January 25, 2011.
14. Granting of authorities in order to formalize and execute the resolutions passed at the General Shareholders’ Meeting.
|
| 2014-12-02 |
除权日：
美东时间 2014-12-04 每股派息0.25美元
|
| 2014-06-04 |
除权日：
美东时间 2014-06-05 每股派息0.01美元
|
| 2014-06-03 |
除权日：
美东时间 2014-06-05 每股派息0.27美元
|
| 2014-04-25 |
股东大会：
将于2014-05-29召开股东大会
会议内容 ▼▲
- 1. Review and approval, as the case may be, of the individual annual accounts and management report, as well as of the proposal for allocation of results relating to fiscal year ended December 31, 2013, and approval of a preferred dividend corresponding to Class B shares.
2. Review and approval, as the case may be, of the consolidated annual accounts and management report relating to fiscal year ended December 31, 2013.
3. Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December 31, 2013.
4. Re-election of auditors of the individual annual accounts.
5. Re-election of auditors of the consolidated annual accounts.
6. Appointment of Ms. Marla E. Salmon as new director of the Company and subsequent increase of the number of members of the Board of Directors.
7. Approval of the Board Members’remuneration.
8. Consultative vote on the Annual Remuneration Report.
9. Renewal of the resolution of share split of the Company’s Class A and Class B shares, in the proportion of 2 new shares (whether of Class A or of Class B) for each 1 of the former shares (whether of Class A or of Class B), as may be applicable, by means of a decrease in their nominal value and the subsequent increase in the number of the Company’s Class A and Class B shares, which will be multiplied by two, without any change to the total nominal value of the share capital, with the consequent renewal of the delegation of authorities to the Board of Directors for a term of 1 year. Amendment of Article 6 of the Company’s Articles of Association (Share Capital). Application before the relevant domestic and foreign authorities for the listing of the new shares on the Stock Exchanges of Madrid, Barcelona, Bilbao and Valencia, as well as on the Spanish Automated Quotation System (Sistema de Interconexión Bursátil) (Continuous Market) and on the NASDAQ. Revocation of the previous delegation of authorities passed by the Extraordinary General Shareholders Meeting of 17 December 2013.
10. Renewal of the delegation to the Board of Directors, with full power of substitution in any of its members, of the authority to apply for the listing of the Company’s ordinary Class A shares on the NASDAQ. Revocation of the previous delegation of authorities passed by the Extraordinary General Shareholders Meeting of 17 December 2013.
11. Granting of authorities in order to formalize and execute the resolutions passed at the General Shareholders’ Meeting.
|
| 2013-11-15 |
股东大会：
将于2013-12-16召开股东大会
会议内容 ▼▲
- 1. Renewal of the resution of share split of the company's Class A and Class B shares, in the proportion of 2 new shares (whether of Class A or of Class B)for each 1 of the former shares (whether ClassA or of Class B), as may be applicable,by means of a decrease in their nominal value and the subsequent increase in the number of the Company's Class A and Class B shares, which will be multiplied by two, whithout any change to the total nominal value of the share capital, with the consequent renewal of the delegation of authorities to the Board of Directors for a term of 1 year, Amendement of Article 6 of the company's Articles of Association (Share Capital). Application before the relevant domestic and foreign authorities for the listing of the new shares on the Stock Exchanges of Madrid, Barcelona,Bilbao and Valencia, as well as on the Spanish Automated Quotation System(Sistema de Interconexion Bursatil)(Continuous Market) and on the NASDAQ.
2.Information to the shareholders on the sigining of a definitive agreement for the acquistion of a diagnostics business unit of the Swiss company Novartis international AG.
3. Renewal of the delegation to the Board of the Directors, with full power of substitution in any of its members, of the authority to apply for the listing of the company's ordinary Class A shares on the NASDAQ.
4. Granting of authorities to formlise and execute the resolutions passed by the General Meeting.
|
| 2013-05-24 |
除权日：
美东时间 2013-06-05 每股派息0.26美元
|
| 2013-05-17 |
除权日：
美东时间 2013-05-29 每股派息0.01美元
|